Poletti Franco 4

Accession 0001639691-25-000023

CIK 0001639691other

View on SEC.gov Company Profile

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 9:00 PM ET

Size

29.1 KB

Accession

0001639691-25-000023

Insider Transaction Report

Form 4

Period: 2025-03-30

LivaNova PLCLIVN

Poletti Franco

President, Cardiopulmonary

Transactions

Exercise/Conversion
Ordinary Shares
2025-03-30+1,257→ 8,475 total
Exercise/Conversion
Restricted Stock Units
2025-03-30−172→ 171 total
→ Ordinary Shares (172 underlying)
Exercise/Conversion
Restricted Stock Units
2025-03-30−559→ 1,675 total
→ Ordinary Shares (559 underlying)
Award
Stock Appreciation Rights
2025-03-30+13,986→ 13,986 total
Exercise: $39.13Exp: 2035-03-30→ Ordinary Shares (13,986 underlying)
Exercise/Conversion
Restricted Stock Units
2025-03-30−201→ 0 total
→ Ordinary Shares (201 underlying)
Exercise/Conversion
Restricted Stock Units
2025-03-30−325→ 650 total
→ Ordinary Shares (325 underlying)
Award
Restricted Stock Units
2025-03-30+6,388→ 6,388 total
→ Ordinary Shares (6,388 underlying)
Tax Payment
Ordinary Shares
2025-03-30$39.13/sh−542$21,208→ 7,933 total
Award
Performance Stock Units
2025-03-30+3,194→ 3,194 total
→ Ordinary Shares (3,194 underlying)
Award
Performance Stock Units
2025-03-30+6,388→ 6,388 total
→ Ordinary Shares (6,388 underlying)
Award
Performance Stock Units
2025-03-30+3,194→ 3,194 total
→ Ordinary Shares (3,194 underlying)

Holdings

Ordinary Shares
(indirect: By Spouse)
219

Footnotes (13)

[F1]Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value.
[F10]On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's free cash flow (FCF) for performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.
[F11]On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.
[F12]On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2025 and ending December 31, 2027 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.
[F13]On March 30, 2025, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.
[F2]Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement.
[F3]On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2022. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement.
[F4]On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement.
[F5]Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement.
[F6]On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.
[F7]On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.
[F8]On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.
[F9]Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement.

Documents

1 file

4
wk-form4_1743555619.xmlPrimary
FORM 4

Issuer

LivaNova PLC

CIK 0001639691

→

Entity typeother

Related Parties

filerCIK 0002031281

Filing Metadata

Form type: 4
Filed: Mar 31, 8:00 PM ET
Accepted: Apr 1, 9:00 PM ET
Size: 29.1 KB

View on SEC.gov